Literature DB >> 4019786

Posttranslational cleavage of proinsulin is blocked by a point mutation in familial hyperproinsulinemia.

Y Shibasaki, T Kawakami, Y Kanazawa, Y Akanuma, F Takaku.   

Abstract

Familial hyperproinsulinemia is characterized by the accumulation of proinsulin-like material (PLM) in the plasma of affected patients. This disorder is inherited in an autosomal dominant fashion. The accumulation of PLM is thought to be due to the impaired conversion of proinsulin to insulin. Although PLM has been suggested to have an amino acid substitution, it has been impossible to locate and identify a substituted amino acid, due to the difficulty in isolating sufficient amounts of PLM from plasma samples. Therefore, we analyzed leukocyte DNA from one member of a proinsulinemic family, and we found a point mutation that changed guanine to adenine in the insulin gene. This transition implies that a substitution of histidine for arginine has occurred at amino acid position 65. Furthermore, it indicates that arginine at 65 is essential for the conversion of proinsulin to insulin. Our results suggest a novel mechanism by which disease can be incurred: a heritable disorder can result from a posttranslational processing abnormality caused by a point mutation.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4019786      PMCID: PMC423787          DOI: 10.1172/JCI111973

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  26 in total

1.  Screening lambdagt recombinant clones by hybridization to single plaques in situ.

Authors:  W D Benton; R W Davis
Journal:  Science       Date:  1977-04-08       Impact factor: 47.728

2.  Biological activity of proinsulin and related polypeptides in the fat tissue.

Authors:  S S Yu; A E Kitbachi
Journal:  J Biol Chem       Date:  1973-06-10       Impact factor: 5.157

3.  A circulating variant of human proalbumin.

Authors:  S O Brennan; R W Carrell
Journal:  Nature       Date:  1978-08-31       Impact factor: 49.962

4.  Sequence of the human insulin gene.

Authors:  G I Bell; R L Pictet; W J Rutter; B Cordell; E Tischer; H M Goodman
Journal:  Nature       Date:  1980-03-06       Impact factor: 49.962

5.  Sequencing end-labeled DNA with base-specific chemical cleavages.

Authors:  A M Maxam; W Gilbert
Journal:  Methods Enzymol       Date:  1980       Impact factor: 1.600

6.  Cloning human fetal gamma globin and mouse alpha-type globin DNA: preparation and screening of shotgun collections.

Authors:  F R Blattner; A E Blechl; K Denniston-Thompson; H E Faber; J E Richards; J L Slightom; P W Tucker; O Smithies
Journal:  Science       Date:  1978-12-22       Impact factor: 47.728

7.  Cloning human fetal gamma globin and mouse alpha-type globin DNA: characterization and partial sequencing.

Authors:  O Smithies; A E Blechl; K Denniston-Thompson; N Newell; J E Richards; J L Slightom; P W Tucker; F R Blattner
Journal:  Science       Date:  1978-12-22       Impact factor: 47.728

8.  Familial hyperproinsulinemia: partial characterization of circulating proinsulin-like material.

Authors:  K H Gabbay; R M Bergenstal; J Wolff; M E Mako; A H Rubenstein
Journal:  Proc Natl Acad Sci U S A       Date:  1979-06       Impact factor: 11.205

9.  Familial hyperproinsulinemia due to a proposed defect in conversion of proinsulin to insulin.

Authors:  P A Gruppuso; P Gorden; C R Kahn; M Cornblath; W P Zeller; R Schwartz
Journal:  N Engl J Med       Date:  1984-09-06       Impact factor: 91.245

10.  Familial hyperproinsulinemia. An autosomal dominant defect.

Authors:  K H Gabbay; K DeLuca; J N Fisher; M E Mako; A H Rubenstein
Journal:  N Engl J Med       Date:  1976-04-22       Impact factor: 91.245

View more
  17 in total

1.  The CpG dinucleotide and human genetic disease.

Authors:  D N Cooper; H Youssoufian
Journal:  Hum Genet       Date:  1988-02       Impact factor: 4.132

Review 2.  Precursors to regulatory peptides: their proteolytic processing.

Authors:  P C Andrews; K Brayton; J E Dixon
Journal:  Experientia       Date:  1987-07-15

3.  Use of a synthetic peptide antigen to generate antisera reactive with a proteolytic processing site in native human proinsulin: demonstration of cleavage within clathrin-coated (pro)secretory vesicles.

Authors:  D F Steiner; J Michael; R Houghten; M Mathieu; P R Gardner; M Ravazzola; L Orci
Journal:  Proc Natl Acad Sci U S A       Date:  1987-09       Impact factor: 11.205

4.  A mutant human proinsulin is secreted from islets of Langerhans in increased amounts via an unregulated pathway.

Authors:  R J Carroll; R E Hammer; S J Chan; H H Swift; A H Rubenstein; D F Steiner
Journal:  Proc Natl Acad Sci U S A       Date:  1988-12       Impact factor: 11.205

Review 5.  The role of the unfolded protein response in diabetes mellitus.

Authors:  Takao Iwawaki; Daisuke Oikawa
Journal:  Semin Immunopathol       Date:  2013-03-26       Impact factor: 9.623

Review 6.  Clinical and molecular genetics of neonatal diabetes due to mutations in the insulin gene.

Authors:  Julie Støy; Donald F Steiner; Soo-Young Park; Honggang Ye; Louis H Philipson; Graeme I Bell
Journal:  Rev Endocr Metab Disord       Date:  2010-09       Impact factor: 6.514

7.  A superactive insulin: [B10-aspartic acid]insulin(human).

Authors:  G P Schwartz; G T Burke; P G Katsoyannis
Journal:  Proc Natl Acad Sci U S A       Date:  1987-09       Impact factor: 11.205

8.  A mutation in the B chain coding region is associated with impaired proinsulin conversion in a family with hyperproinsulinemia.

Authors:  S J Chan; S Seino; P A Gruppuso; R Schwartz; D F Steiner
Journal:  Proc Natl Acad Sci U S A       Date:  1987-04       Impact factor: 11.205

9.  Molecular basis of hemophilia B: a defective enzyme due to an unprocessed propeptide is caused by a point mutation in the factor IX precursor.

Authors:  D L Diuguid; M J Rabiet; B C Furie; H A Liebman; B Furie
Journal:  Proc Natl Acad Sci U S A       Date:  1986-08       Impact factor: 11.205

10.  Insulin gene mutations resulting in early-onset diabetes: marked differences in clinical presentation, metabolic status, and pathogenic effect through endoplasmic reticulum retention.

Authors:  Gargi Meur; Albane Simon; Nasret Harun; Marie Virally; Aurélie Dechaume; Amélie Bonnefond; Sabrina Fetita; Andrei I Tarasov; Pierre-Jean Guillausseau; Trine Welløv Boesgaard; Oluf Pedersen; Torben Hansen; Michel Polak; Jean-François Gautier; Philippe Froguel; Guy A Rutter; Martine Vaxillaire
Journal:  Diabetes       Date:  2009-12-10       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.